GO
Loading...

Medtronic Inc

More

  • Midday Glance: Medical Devices companies Friday, 12 Sep 2014 | 1:19 PM ET

    Allergan rose$. 56 or. 3 percent, to $168.89. Baxter International Inc. fell$. 43 or. 6 percent, to $74.66. Boston Scientific Corp. fell$. 03 or. 2 percent, to $12.51.

  • Early Glance: Medical Devices companies Friday, 12 Sep 2014 | 11:13 AM ET

    Allergan fell$. 22 or. 1 percent, to $168.12. Baxter International Inc. fell$. 26 or. 3 percent, to $74.83. St. Jude Medical Inc. fell$. 38 or. 6 percent, to $64.45.

  • Final Glance: Medical Devices companies Thursday, 11 Sep 2014 | 6:02 PM ET

    Allergan rose $1.60 or 1.0 percent, to $168.33. Baxter International Inc. fell$. 19 or. 3 percent, to $75.09. Boston Scientific Corp. rose$. 03 or. 2 percent, to $12.54.

  • Midday Glance: Medical Devices companies Thursday, 11 Sep 2014 | 2:09 PM ET

    Allergan rose$. 64 or. 4 percent, to $167.37. Baxter International Inc. fell$. 19 or. 2 percent, to $75.10. Boston Scientific Corp. fell$. 04 or. 3 percent, to $12.48.

  • NEW YORK, Sept 11- U.S. specialty drugmaker Akorn Inc is exploring a bid for Belgian drugmaker UCB SA's U.S. subsidiary, a deal that would allow the company to move its tax domicile overseas in a practice known as inversion, according to people familiar with the matter.

  • Early Glance: Medical Devices companies Thursday, 11 Sep 2014 | 10:29 AM ET

    Allergan rose$. 26 or. 2 percent, to $166.99. Baxter International Inc. fell$. 28 or. 4 percent, to $75.00. Boston Scientific Corp. fell$. 01 or. 1 percent, to $12.50.

  • Final Glance: Medical Devices companies Wednesday, 10 Sep 2014 | 6:16 PM ET

    Allergan rose$. 61 or. 4 percent, to $166.73. Baxter International Inc. rose $1.01 or 1.4 percent, to $75.28. Boston Scientific Corp. rose$. 13 or 1.1 percent, to $12.51.

  • Midday Glance: Medical Devices companies Wednesday, 10 Sep 2014 | 1:21 PM ET

    Allergan rose $1.18 or. 7 percent, to $167.30. Baxter International Inc. rose$. 84 or 1.1 percent, to $75.11. Boston Scientific Corp. rose$. 15 or 1.2 percent, to $12.53.

  • Early Glance: Medical Devices companies Wednesday, 10 Sep 2014 | 10:32 AM ET

    Allergan fell$. 48 or. 3 percent, to $165.65. Baxter International Inc. rose$. 44 or. 6 percent, to $74.71. Boston Scientific Corp. rose$. 06 or. 5 percent, to $12.44.

  • Final Glance: Medical Devices companies Tuesday, 9 Sep 2014 | 8:15 PM ET

    Allergan fell$. 82 or. 5 percent, to $166.12. Baxter International Inc. rose$. 05 or. 1 percent, to $74.27. Boston Scientific Corp. rose$. 06 or. 5 percent, to $12.38.

  • Midday Glance: Medical Devices companies Tuesday, 9 Sep 2014 | 1:22 PM ET

    Allergan fell$. 14 or. 1 percent, to $166.80. Baxter International Inc. rose$. 12 or. 2 percent, to $74.34. Johnson& Johnson fell$. 16 or. 2 percent, to $103.89.

  • Early Glance: Medical Devices companies Tuesday, 9 Sep 2014 | 10:26 AM ET

    Allergan fell$. 75 or. 4 percent, to $166.19. Baxter International Inc. rose$. 04 or. 1 percent, to $74.26. Boston Scientific Corp. fell$. 07 or. 6 percent, to $12.25.

  • NEW YORK, Sept 3- Some of the best-known technology investors are looking beyond their tried-and-true Internet plays to bet on healthcare data as the next growth market.

  • Public pension funds stay mum on tax inversions Tuesday, 2 Sep 2014 | 8:07 AM ET
    The offices of the California Public Employees' Retirement System (Calpers) are shown in Sacramento, Calif.

    Public pension funds have major stakes in American firms moving overseas to cut their tax bills. But they are saying little about the strategy.

  • Aug 28- Johnson& Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter. Earlier this year, J&J sold another of its units, Ortho-Clinical Diagnostics Inc to private-equity firm Carlyle Group for $4.15 billion.

  • Bankers and lawyers providing takeover advice said on Monday that Burger King Worldwide Inc's intention to move its tax domicile overseas through a so-called inversion deal- in this case the purchase of Canada's Tim Hortons- shouldn't be seen as a sign of a lot more deals to come.

  • Burger King in merger talks with Tim Hortons Sunday, 24 Aug 2014 | 9:28 PM ET

    Burger King is in talks to combine with Tim Hortons in a deal that would create a powerhouse with a market capitalization of roughly $18 billion.

  • *Deal boosts Roche presence in respiratory medicine. LONDON/ ZURICH, Aug 24- Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.

  • Roche to purchase InterMune in $8.3 billion deal Sunday, 24 Aug 2014 | 12:27 PM ET

    Biotech firm Roche announced plans Sunday to buy InterMune for $8.3 billion on a fully diluted basis in an all-cash transaction.

  • Aug 19- Medtronic Inc Chief Executive Omar Ishrak defended his company's plan to acquire Dublin- based Covidien Plc in a so-called inversion deal, saying the medical device maker will be able to create more U.S. jobs while still paying substantial taxes once the transaction closes.